University of Missouri-Columbia
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, University of Missouri-Columbia sits in the top decile of US sponsors by registered trial count (#120 of 15,742 sponsors by registered trial count).
University of Missouri-Columbia: 291 sponsored US clinical trials, 54 recruiting.
University of Missouri-Columbia sponsors 291 registered US clinical trials on ClinicalTrials.gov, 54 of them currently recruiting, and 170 completed. 29 of these trials are in Phase 3-4 (later-stage) and 38 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 8 trials.
Top-decile sponsor footprint
University of Missouri-Columbia ranks in the top decile of sponsors by registered trial count (#120 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
170 of 224 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (75.9%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
291 total, page 1 of 6
The Feasibility of a Remote Problem-Solving Intervention for Autistic Adolescents or Young Adults and a Caregiver
NCT07216196
Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
NCT07478172
Impact of Sleep Restriction on Blood Pressure Reactivity
NCT07489417
Evaluation of Cognitive Behavioral Therapy for Insomnia (CBT-I) in Individuals With Mild Traumatic Brain Injury (mTBI)
NCT07385105
Carbo-fix Lateral Plate Devices and Standard Plate-Nail Constructs in Distal Femur Fractures
NCT07280169
Impact of Phenylalanine Elevations on Brain and Cognition in Adult PKU Carriers
NCT07220265
Effects of Grape Consumption on the Immune-Gut Axis in Obesity
NCT07231484
Pars Healing on MRI
NCT07215845
Investigating Phenotypic, Epigenetic, and NeuroGenetic Traits in Rare and Ultra-rare Neurodevelopmental Disorders (Project PENGUIN)
NCT07329257
7T Brain MRI Scan for Micro-brain Metastasis (microBM) Detection for Patients With Small-cell Lung Cancer (SCLC), Who Decline Prophylactic Cranial Irradiation (PCI)
NCT07175077
Open Pilon With FIBERGRAFT AERIDYAN Matrix Bioactive Glass
NCT07227493
Growth Hormone Resistance of Beta-cells
NCT06571487
Effects of Whole-body Electrical Muscle Stimulation Exercise on Spinal Motoneuronal Activation in Older Adults
NCT06689618
Growth Hormone Resistance of Beta-cells in Women and People
NCT06571500
Sympathetic Vascular Transduction Across the Menopause Transition: Contributing Mechanisms
NCT06787066
Intrauterine Device Insertion Pain Management
NCT06951191
Examining the Role of Executive Functioning in Family-Based Intensive Health Behavior and Lifestyle Treatment
NCT06969235
Brain Blood Flow and Lactate in Non-obese and Obese Subjects
NCT06791837
Propranolol in Primary Progressive Aphasia
NCT06066710
Study of Fetal Health Outcomes: Working With a Missouri E-telehealth Platform (The SHOW-ME Study)
NCT06741735
Improving Participation After Stroke Self-Management-Rehabilitation
NCT06588647
Cognitive Rehabilitation Following Breast Cancer Treatment
NCT06545045
Development of Novel Psychological Assessment Tools and Anxiety Intervention for Phenylketonuria
NCT06560736
NeuroControl of Nicotine Dependence
NCT06347055
Early Neurovascular Adaptations in Aging Women
NCT06520982
Empagliflozin Reversal of Arterial StiffnEss in Aging
NCT06506422
Remote Sensing for ADRD-Specific Activities Identification in Older Adults
NCT07120347
Effects of Lean Beef Consumption on Cardiometabolic Health and Gut Microbiome
NCT06433115
Impact of Early Aging and Menopause on the Vascular Responses to Hypoxia
NCT06417177
Baker Gordon Syndrome Natural History Study
NCT06399952
Accelerated ART Initiation for PWHIV Who Are Out of Care
NCT06374758
Absorbable vs Non-Absorbable Sutures for Hip Capsular Closure
NCT06845735
Sleep as a Mechanism of Change in Alcohol Use
NCT06286774
Impact GLP-1 Agonists Following Bariatric
NCT06132477
CAT BITE Antibiotic Prophylaxis for the Hand/Forearm (CATBITE)
NCT05846399
Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Myasthenia Gravis
NCT06064695
Effect of Drain Care on Infection Rate and Quality of Life in Implant-Based Breast Reconstruction.
NCT05846438
Sex Disparities in Hypoxic Vasodilation and Impact of Obesity
NCT05219799
High Protein Diet and Atherosclerosis
NCT05235464
Lipoprotein Kinetics in T1D
NCT05179954
Skin Preparation for Elective Foot and Ankle Surgery
NCT05401292
Dietary Fiber Effects on the Microbiome and Satiety
NCT04611217
Testing Less Intensive Radiation With Chemotherapy to Treat Low-risk Patients With HPV-positive Oropharyngeal Cancer
NCT04444869
Targeting Insomnia in School Aged Children With Autism Spectrum Disorder
NCT04545606
Membrane Target Detection for Leukemia Treatment
NCT04841447
Smoking Cessation Behavioral Treatment Study
NCT03948893
Subjective Intraoperative Use of Epidural Steroid Administration Following Discectomy
NCT04182997
Animal and Plant Proteins and Glucose Metabolism
NCT03994367
An fMRI Study of the Effects of Clavulanic Acid on Drug Addiction
NCT03713424
Pilon Fracture With Intra-articular Injection of N-Acetylcysteine (Pilon NAC)
NCT03652753
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 26 |
| Phase 2 | 12 |
| Phase 3 | 4 |
| Phase 4 | 25 |
Therapeutic Areas
What is open in the University of Missouri-Columbia pipeline
54 recruiting of 291 indexed (19% open); 170 completed (58%).
Phase mix: 29 late (III/IV) vs 38 early (I/II) (balanced across stages).
Top condition: Obesity (8 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Missouri-Columbia: open-pipeline peers nationwide
Peers matched on 291 registered trials and 19% open enrollment, not the therapeutic-area sidebar.
University of Missouri-Columbia sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 291 trials (± recruiting share)
- Thomas Jefferson University · 292 trials · 18% recruiting
- University of Michigan Rogel Cancer Center · 292 trials · 15% recruiting
- Kaiser Permanente · 294 trials · 7% recruiting
- Eisai · 287 trials · 2% recruiting
Sponsors near 19% open enrollment (± trial volume)
- Arkansas Children's Hospital Research Institute · 19% recruiting · 97 trials
- Montefiore Medical Center · 19% recruiting · 345 trials
- Children's Hospital Medical Center, Cincinnati · 19% recruiting · 571 trials
- Mclean Hospital · 19% recruiting · 140 trials
Related
What to do with this University of Missouri-Columbia page
291 registered trials is a research-attention snapshot, not an endorsement of University of Missouri-Columbia or any single study.
- 54 of University of Missouri-Columbia's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition University of Missouri-Columbia studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Missouri-Columbia pipeline card: 291 registered trials from official public datasets.Report a data error.